“The Changing Landscape of Mineralocorticoid Receptor Antagonists – Finerenone in Cardiovascular and Renal Health”. Prospects in Pharmaceutical Sciences, vol. 22, no. 1, Feb. 2024, pp. 11-15, https://doi.org/10.56782/pps.181.